Skip to main content
2024 Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Educational Accreditation

Target Audience

The 2024 ACCP Annual Meeting will be of educational benefit to pharmacists, physicians, clinical researchers, physician assistants and clinical pharmacology professionals from academia, regulatory, industry, consulting and clinical healthcare involved in the discovery, development and/or application of drug therapies in patient care.

Learning Objectives

As a result of attending this meeting, the learner will be able to:
  1. Identify new innovations in drug discovery, clinical development & regulatory science that are relevant to streamlining clinical development;
  2. Define model-informed drug development and describe the utility of quantitative approaches in drug discovery & development;
  3. Describe emerging trends in the study of clinical pharmacology in special populations, including generalizability & limitations of applying general population data to these clinical groups;
  4. Explore ways in which cutting-edge clinical pharmacology science contributes to patient care decisions at the bedside.

Accreditation Statements

The American College of Clinical Pharmacology® is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of Continuing Pharmacy Education (CPE).

The ACPE Universal Activity Numbers (UAN), amount of Contact Hours available and CPE target audience designations, are noted within each course of the program for a maximum of 23.5 Contact Hours. Pharmacists should claim only the Contact Hours commensurate with the extent of their participation in the activity.

The American College of Clinical Pharmacology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Continuing Medical Education (CME) for physicians.





Designation Statement

The American College of Clinical Pharmacology designates this Live educational activity for a maximum of 23.5 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Disclosure: Requirements for Successful Completion

Attendees requesting CME/CPE credits must indicate their credit request during registration for the 2024 ACCP Annual Meeting. Attendees wishing to obtain credits must attend one or more CME/CPE courses and complete the requisite course’s Self-assessment Post-test, Evaluation, claim the credits and PRINT the Certificate(s) no later than October 31, 2024. Beyond that point, requests to complete CME/CPE post-event processes will incur an administrative late fee of $200 and must be finalized no later than December 31, 2024.

Disclosure: Additional CPE Requirements

Attendees seeking CPE credit must also provide ACCP with their National Association of Boards of Pharmacy (NABP) Profile Number and the month and day of their birth via email to CE@ACCP1.org. The NABP Profile Number and birthday information is required for ACCP to transmit CPE credit information via the CPE Monitor. ACCP cannot report CPE credits for individuals who fail to provide their NABP Profile Number and correct MMDD of birth to ACCP during registration.

Disclosure to Learners

Planners, Faculty and others in control of content for this educational activity have disclosed relevant financial relationship(s) with ineligible companies. All of the relevant financial relationships listed for these individuals have been mitigated. A full list of disclosures will be provided in early September.